IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, ...
Le Lézard25m
IQVIA named to the Fortune® World's Most Admired Companiestm list, ranked No. 1 in its sector for fourth consecutive year
IQVIA , a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World's Most Admired Companiestm ...
Le Lézard57s
Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care
One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they ...
Hosted on MSN47m
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
JB Pharma Q3 net profit jumps 22% to Rs 162 crore
JB Pharma on Tuesday reported a 22% year-on-year (Y-o-Y) jump in net profit to Rs 162 crore for the quarter ended December 31 ...
cnbctv1845m
Lupin confirms getting tentative USFDA nod for HIV drug
The company has received tentative approval from the US Food and Drug Administration (USFDA) for Darunavir, Cobicistat, ...